Sanofi Statistics

Share Statistics

Sanofi has 1.22B shares outstanding. The number of shares has increased by -2.81% in one year.

Shares Outstanding	1.22B
Shares Change (YoY)	-2.81%
Shares Change (QoQ)	-0.47%
Owned by Institutions (%)	n/a
Shares Floating	1.11B
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 378.17K, so 0.03% of the outstanding shares have been sold short.

Short Interest	378.17K
Short % of Shares Out	0.03%
Short % of Float	0.03%
Short Ratio (days to cover)	4.61

Valuation Ratios

The PE ratio is 20.64 and the forward PE ratio is 9.83. Sanofi's PEG ratio is 5.92.

PE Ratio	20.64
Forward PE	9.83
PS Ratio	2.59
Forward PS	2
PB Ratio	1.48
P/FCF Ratio	19.49
PEG Ratio	5.92

Financial Ratio History

Enterprise Valuation

Sanofi has an Enterprise Value (EV) of 125.21B.

EV / Sales	2.83
EV / EBITDA	11.35
EV / EBIT	13.79
EV / FCF	21.27

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.

Current Ratio	1.46
Quick Ratio	1.14
Debt / Equity	0.23
Debt / EBITDA	1.62
Debt / FCF	3.04
Interest Coverage	19.29

Financial Efficiency

Return on Equity is 7.17% and Return on Invested Capital is 10.99%.

Return on Equity	7.17%
Return on Assets	4.19%
Return on Invested Capital	10.99%
Revenue Per Employee	$534.35K
Profits Per Employee	$67.09K
Employee Count	82,878
Asset Turnover	0.33
Inventory Turnover	1.4

Taxes

Income Tax	1.2B
Effective Tax Rate	17.82%

Stock Price Statistics

The stock price has increased by -11.28% in the last 52 weeks. The beta is 0.41, so Sanofi's price volatility has been higher than the market average.

Beta	0.41
52-Week Price Change	-11.28%
50-Day Moving Average	97.34
200-Day Moving Average	102.5
Relative Strength Index (RSI)	41.05
Average Volume (20 Days)	47,596

Income Statement

In the last 12 months, Sanofi had revenue of 44.29B and earned 5.56B in profits. Earnings per share was 4.45.

Revenue	44.29B
Gross Profit	31.08B
Operating Income	14.45B
Net Income	5.56B
EBITDA	11.03B
EBIT	7.45B
Earnings Per Share (EPS)	4.45

Full Income Statement

Balance Sheet

The company has 7.44B in cash and 17.91B in debt, giving a net cash position of -10.46B.

Cash & Cash Equivalents	7.44B
Total Debt	17.91B
Net Cash	-10.46B
Retained Earnings	n/a
Total Assets	124.96B
Working Capital	7.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.08B and capital expenditures -3.19B, giving a free cash flow of 5.89B.

Operating Cash Flow	9.08B
Capital Expenditures	-3.19B
Free Cash Flow	5.89B
FCF Per Share	4.71

Full Cash Flow Statement

Margins

Gross margin is 70.18%, with operating and profit margins of 32.63% and 12.55%.

Gross Margin	70.18%
Operating Margin	32.63%
Pretax Margin	15.26%
Profit Margin	12.55%
EBITDA Margin	24.91%
EBIT Margin	32.63%
FCF Margin	13.29%

Dividends & Yields

SNYNF pays an annual dividend of $8.43, which amounts to a dividend yield of 4.14%.

Dividend Per Share	$8.43
Dividend Yield	4.14%
Dividend Growth (YoY)	8.16%
Payout Ratio	141.22%
Earnings Yield	4.85%
FCF Yield	5.13%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for SNYNF.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$22.25
Lynch Upside	-76.03%
Graham Number	78.81
Graham Upside	-15.11%

Stock Splits

The last stock split was on May 6, 2022. It was a forward split with a ratio of 1005:1000.

Last Split Date	May 6, 2022
Split Type	forward
Split Ratio	1005:1000

Scores

Altman Z-Score	1.87
Piotroski F-Score	6

Sanofi (SNYNF)